News

Decision and Order denying Valeant Pharmaceuticals International, Inc.’s, Motion for Summary Judgment and granting Mimetogen Pharmaceutical Inc.’s Motion for Partial Summary Judgment issued on behalf of SLG’s client,...

New York federal court denies motion to dismiss (in part) and permits SLG’s client, Mimetogen Pharmaceuticals, Inc., to pursue extra-contractual damages outside of contractual limitation on liability in breach of contract...

Former Harmonix Stockholders Defeat Viacom International’s Motion to Dismiss; Judge Rules that Case May Proceed. Read Judge Eric M. Davis’s Opinion regarding SLG client, Walter Winshall, representing former Harmonix...

Bausch & Lomb Incorporated v. Mimetogen Pharmaceuticals Inc.: David Shlansky, Esq., quoted in Financial Post article regarding SLG’s client, Mimetogen Pharmaceuticals Inc., and its dispute with Bausch & Lomb...

Client Update: SLG’s Colin Hagan recently completed an extensive examination of the “Manager Rule” and has compiled his findings in the article titled ‘”Manager Rule” Not the Rule in Fourth Circuit.’ Read the...